This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Texas Health Science Center at Houston (UTHealth), a state-controlled institution of higher learning, for an Elastomeric Respirator Study. The firm fixed-price contract has a potential value of $833,009.00 and a completion date of August 31, 2023. The contract is not set aside. As a prime contractor, UTHealth has provided research services,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $275,000.00 definitive, firm fixed price contract to the University of Texas Health Science Center at Houston (UTHealth) for INVASIVE MOLD INFECTION DATA ACQUISITION services. This contract has no set-aside designation and was completed on September 30, 2020. UTHealth is a state-controlled institution of higher learning that provides healthcare services, medical education, and biomedical research. As...
This federal contract award, valued at $906,699.00, was granted to the University of Texas Health Science Center at Houston (UTHealth) by the Shared Services Center, a civilian agency. The contract is for a research grant focused on the impacts of nighttime lighting in modern societies. As a state-controlled institution of higher learning, UTHealth has extensive capabilities in biomedical research, clinical trials, and translational science. The University of Texas System, the parent...
This is a $449,000.00 definitive contract awarded by a U.S. government agency to the University of Texas Health Science Center at Houston (UTHealth), which is the prime contractor. The contract is a cost-no-fee type and does not have a set-aside designation. UTHealth is providing a range of healthcare research, clinical trials, data analytics, and administrative support services under this award. UTHealth is a comprehensive academic health university in Texas that frequently partners with...
This federal contract award for $4,209,368.29 was made by the National Heart Lung and Blood Institute, part of the National Institutes of Health, to the University of Texas Health Science Center at Houston (UTHealth). The contract, titled "THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL", does not have a set-aside designation and is a definitive contract with a cost-no-fee pricing type. UTHealth is a subcomponent of the larger University of Texas System,...
This federal contract award is for a Definitive Contract with a ceiling value of $734,730.60 issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency. The contract was awarded to the University of Texas at Austin, a public research university, to perform work under Broad Agency Announcement (BAA) Topic 20.2 - "Estimating the Effects of COVID-19 Non-Pharmaceutical Interventions on the Burden of Influenza in the U.S." The University of Texas...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Texas Health Science Center at Houston (UTHealth) for library prep and next generation genome sequencing of influenza A virus. The contract has a potential value of $17,800.00 and a completion date of February 20, 2018. UTHealth is a U.S. Government Entity registered as an Educational...
This is a firm fixed price purchase order contract awarded by the National Institute for Minority Health and Disparities (NIMHD) to the University of Texas Health Science Center at Houston (UTHealth) for a Prospective Cohort Data Analyses Project. The $43,923 contract supports research services related to the NIMHD's mission. UTHealth, a state-controlled institution of higher learning, will provide the requested data analysis services. This contract award is not associated with a larger contract...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $99,916.68 fixed-price with economic price adjustment delivery order contract by the Department of Veterans Affairs (VA) to provide research services with an academic affiliate. The contract, which has a period of performance through August 31, 2025, was awarded on September 1, 2024 under an indefinite delivery vehicle established between UTHealth and the VA for research support. This contract is not set-aside....
This federal contract award, valued at $250,000.00, was granted by the Centers for Disease Control and Prevention (CDC) to the University of Texas at Austin (UT Austin). The contract is for the "STRENGTHENING PERTUSSIS SURVEILLANCE AND DIAGNOSTICS BY IMPROVEMENTS IN ANTIGEN PRODUCTION", with a period of performance ending on September 29, 2026. The contract is a definitive contract with a cost-no-fee pricing type, and there is no set-aside designation. As a major research university,...